Understanding Why Immunotherapy Doesn't Always Work for Cancer
Immune Exclusion in Cancer Immunotherapy
['FUNDING_R01'] · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · NIH-11141085
This research explores why immunotherapy treatments don't help all patients with advanced solid tumors, hoping to find new ways to make these treatments more effective.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF PITTSBURGH AT PITTSBURGH (nih funded) |
| Locations | 1 site (PITTSBURGH, UNITED STATES) |
| Trial ID | NIH-11141085 on ClinicalTrials.gov |
What this research studies
Many patients with solid tumors do not respond to current immunotherapy treatments, which can be frustrating. This project aims to understand why some tumors resist these powerful therapies by looking closely at the area around the tumor, called the tumor microenvironment. We are focusing on a specific pathway within tumor cells, called p38 MAPK, which appears to prevent immune cells from effectively attacking the cancer. By understanding how this pathway works, especially in certain head and neck cancers, we hope to discover new ways to make immunotherapy more successful for more patients.
Who could benefit from this research
Good fit: This research is most relevant for patients with advanced solid tumors, particularly those with head and neck squamous cell carcinoma not caused by HPV, who have not benefited from current immunotherapy.
Not a fit: Patients with early-stage cancers or those whose tumors already respond well to existing immunotherapy may not directly benefit from this particular line of investigation.
Why it matters
Potential benefit: If successful, this work could lead to new treatment strategies or combinations that help more patients with advanced cancers respond to immunotherapy.
How similar studies have performed: While the concept of immune exclusion is known, this project explores a newly identified role for a specific pathway within tumor cells, making this a novel area of investigation.
Where this research is happening
PITTSBURGH, UNITED STATES
- UNIVERSITY OF PITTSBURGH AT PITTSBURGH — PITTSBURGH, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BAO, RIYUE — UNIVERSITY OF PITTSBURGH AT PITTSBURGH
- Study coordinator: BAO, RIYUE
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Advanced Cancer